Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating CKD-391 and CKD-331 for primary hypercholesterolemia is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• CKD-331
• CKD-391

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Primary Hypercholesterolemia | Phase 3 | Status: UNKNOWN